Development of a Dose Regimen for Obeticholic Acid in Patients with Primary Biliary Cholangitis and Hepatic Impairment

被引:0
|
作者
Edwards, Jeffrey [1 ]
LaCerte, Carl [1 ]
Peyret, Thomas [2 ]
Gosselin, Nathalie H. [2 ]
Marier, J. F. [2 ]
机构
[1] Intercept Pharmaceut Inc, San Diego, CA USA
[2] Pharsight, Princeton, NJ USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
296
引用
收藏
页码:167A / 167A
页数:1
相关论文
共 50 条
  • [31] Management of primary biliary cholangitis prior to obeticholic acid availability
    Durazzo, Marilena
    Bonetto, Silvia
    Fagoonee, Sharmila
    Morgando, Anna
    Pellicano, Rinaldo
    MINERVA MEDICA, 2018, 109 (06) : 410 - 417
  • [32] The Appropriate Timing and Dose of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
    Dong, Rui
    Zheng, Shan
    Chen, Gong
    GASTROENTEROLOGY, 2015, 149 (02) : 508 - 508
  • [33] REAL WORLD EFFECTIVENESS OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: THE GLOBAL EXPERIENCE
    Gulamhusein, Aliya F.
    Roberts, Surain B.
    Haliday, Neil
    Carbone, Marco
    D'Amato, Daphne
    Yimam, Kidist K.
    Namphuong Tran
    Floreani, Annarosa
    Cazzagon, Nora
    Kanagalingam, Gowthami
    Aziz, Bishoi
    Rupp, Christian
    Colapietro, Francisca
    Lleo, Ana
    Zigmond, Ehud
    Reig, Anna
    Pares, Albert
    Invernizzi, Pietro
    Mason, Andrew L.
    Thorburn, Douglas
    Hirschfield, Gideon M.
    Hansen, Bettina E.
    Trivedi, Palak
    HEPATOLOGY, 2020, 72 : 761A - 762A
  • [34] OBETICHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVED COLLAGEN MORPHOMETRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Kremer, Andreas E.
    Bowlus, Christopher L.
    Bedossa, Pierre
    Pares, Albert
    Forman, Lisa M.
    Drenth, Joost P. H.
    Ryder, Stephen
    Terracciano, Luigi
    Jin, Yuying
    Liberman, Alexander
    Pencek, Richard
    MacConell, Leigh
    Pockros, Paul J.
    GUT, 2019, 68 : A110 - A111
  • [35] CHANGE IN BILIRUBIN WITH OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS PATIENTS WITH HIGH BASELINE BILIRUBIN
    Shapiro, David
    Hirschfield, Gideon
    Shiffman, Mitchell
    Pares, Albert
    Malecha, Elizabeth Smoot
    Pencek, Richard
    MacConell, Leigh
    GUT, 2018, 67 : A112 - A112
  • [36] SURVIVAL OF PATIENTS WITH DECOMPENSATED PRIMARY BILIARY CHOLANGITIS IN THE ERA OF OBETICHOLIC ACID AND MELD 3.0
    Sedki, Mai
    Chung, Nakia L.
    Goel, Aparna
    Montano-Loza, Aldo J.
    Kwong, Allison J.
    Sasaki, Kazunari
    Kim, W. Ray
    Mannalithara, Ajitha
    HEPATOLOGY, 2023, 78 : S2075 - S2076
  • [37] PREDICTION OF LIVER FAILURE IN CIRRHOTIC PRIMARY BILIARY CHOLANGITIS PATIENTS UNDER OBETICHOLIC ACID
    De Vincentis, Antonio
    D'Amato, Daphne
    Vigano, Mauro
    Marzioni, Marco
    Giannini, Edoardo G.
    Pompili, Maurizio
    Cazzagon, Nora
    Muratori, Luigi
    Lleo, Ana
    Calvaruso, Vincenza
    Marconi, Giulia
    Degasperi, Elisabetta
    Abenavoli, Ludovico
    Brunetto, Maurizia R.
    Vanni, Ester
    Colapietro, Francesca
    Pellicano, Rinaldo
    Romana Ponziani, Francesca
    Labanca, Sara
    Morgando, Anna
    Coco, Barbara
    Galati, Giovanni
    Morelli, Olivia
    Cannavo, Mariarita
    Chessa, Luchino
    Cuccorese, Giuseppe
    Russello, Maurizio
    Di Stefano, Marco
    Cozzolongo, Raffaele
    D'Anto, Maria
    Scifo, Gaetano
    Palitti, Valeria Pace
    Fontana, Rossana
    Niro, Grazia Anna
    Rosina, Floriano
    Pellicelli, Adriano
    Sacco, Rodolfo
    Saitta, Carlo
    Fiorini, Cecilia
    Zolfino, Teresa
    Storato, Silvia
    Simone, Loredana
    Marra, Fabio
    Picardi, Antonio
    Invernizzi, Pietro
    Claar, Ernesto
    Izzi, Antonio
    Vespasiani-Gentilucci, Umberto
    Carbone, Marco
    HEPATOLOGY, 2021, 74 : 775A - 776A
  • [38] Obeticholic Acid in Patients with primary biliary Cholangitis - Clinical Results in 2 Kaerntner Centers
    Bota, Simona
    Hucke, Florian
    Thoma, Bernd
    Flatscher, Kerstin
    Peck-Radosavljevic, Markus
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 261 - 261
  • [39] New developments in the treatment of primary biliary cholangitis - role of obeticholic acid
    Jhaveri, Manan A.
    Kowdley, Kris V.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1053 - 1060
  • [40] Real world effectiveness of Obeticholic Acid in the treatment of Primary Biliary Cholangitis
    Ayyagari, Asha
    Ankoma-Sey, Victor
    Egwim, Chukwuma I.
    Vaquerano, Laura B.
    Pham, Julie
    Nazario, Hector E.
    Doan, Elena I.
    Proffitt, Melanie
    Gonzalez, Stevan A.
    Modi, Apurva A.
    HEPATOLOGY, 2017, 66 : 202A - 202A